Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-002913
Filing Date
2018-03-09
Accepted
2018-03-09 17:12:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1834039
2 filename2.htm EX-21 2354
3 GRAPHIC g522368g19c10.jpg GRAPHIC 132105
4 GRAPHIC g522368g20i14.jpg GRAPHIC 131580
5 GRAPHIC g522368g29x80.jpg GRAPHIC 136035
6 GRAPHIC g522368g43z47.jpg GRAPHIC 83090
7 GRAPHIC g522368g47p15.jpg GRAPHIC 163623
8 GRAPHIC g522368g73n73.jpg GRAPHIC 47677
  Complete submission text file 0000950123-18-002913.txt   2794228
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 1 (872) 225-6077
Iterum Therapeutics Ltd (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01913 | Film No.: 18680995
SIC: 2834 Pharmaceutical Preparations